Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byoung Y Ryu

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of General Virology|March 18, 2008
The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteinsByoung Y Ryu, Tatiana Zavorotinskaya, Bernadette Trentin, et al.
Journal of Virology|October 21, 2011
Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsFang Li, Byoung Y Ryu, Robin L Krueger, et al.
European Journal of Immunology|February 8, 2012
Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cellsSarah F Andrews, Xuezhi Dai, Byoung Y Ryu, et al.
Nucleic Acids Research|September 14, 2011
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectorsAshok D Bandaranayake, Colin Correnti, Byoung Y Ryu, et al.
Plos One|March 15, 2011
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniIMartine Aubert, Byoung Y Ryu, Lindsey Banks, et al.
Blood Cells, Molecules & Diseases|July 3, 2007
A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cellsByoung Y Ryu, Derek A Persons, Marguerite V Evans-Galea, et al.
Blood|November 10, 2007
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationByoung Y Ryu, Marguerite V Evans-Galea, John T Gray, et al.
Nature Methods|July 12, 2011
Tracking genome engineering outcome at individual DNA breakpointsMichael T Certo, Byoung Y Ryu, James E Annis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2010
Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disordersBlythe D Sather, Byoung Y Ryu, Brigid V Stirling, et al.
Blood|January 23, 2010
B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemiaHannah M Kerns, Byoung Y Ryu, Brigid V Stirling, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of General Virology|March 18, 2008
The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteinsByoung Y Ryu, Tatiana Zavorotinskaya, Bernadette Trentin, et al.
Journal of Virology|October 21, 2011
Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteinsFang Li, Byoung Y Ryu, Robin L Krueger, et al.
European Journal of Immunology|February 8, 2012
Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cellsSarah F Andrews, Xuezhi Dai, Byoung Y Ryu, et al.
Nucleic Acids Research|September 14, 2011
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectorsAshok D Bandaranayake, Colin Correnti, Byoung Y Ryu, et al.
Plos One|March 15, 2011
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniIMartine Aubert, Byoung Y Ryu, Lindsey Banks, et al.
Blood Cells, Molecules & Diseases|July 3, 2007
A chromatin insulator blocks interactions between globin regulatory elements and cellular promoters in erythroid cellsByoung Y Ryu, Derek A Persons, Marguerite V Evans-Galea, et al.
Blood|November 10, 2007
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationByoung Y Ryu, Marguerite V Evans-Galea, John T Gray, et al.
Nature Methods|July 12, 2011
Tracking genome engineering outcome at individual DNA breakpointsMichael T Certo, Byoung Y Ryu, James E Annis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2010
Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disordersBlythe D Sather, Byoung Y Ryu, Brigid V Stirling, et al.
Blood|January 23, 2010
B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemiaHannah M Kerns, Byoung Y Ryu, Brigid V Stirling, et al.
Pageof 2